ArticleFrontiers in pharmacology2024

Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study.

Helison R P Carmo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.